These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 16939434)

  • 1. Dronedarone: an emerging agent with rhythm- and rate-controlling effects.
    Wegener FT; Ehrlich JR; Hohnloser SH
    J Cardiovasc Electrophysiol; 2006 Sep; 17 Suppl 2():S17-20. PubMed ID: 16939434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dronedarone therapy in atrial fibrillation: a summary of recent controlled trials.
    Duray GZ; Schmitt J; Hohnloser SH
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):19S-23S. PubMed ID: 20472812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study.
    Davy JM; Herold M; Hoglund C; Timmermans A; Alings A; Radzik D; Van Kempen L;
    Am Heart J; 2008 Sep; 156(3):527.e1-9. PubMed ID: 18760136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).
    Page RL; Connolly SJ; Crijns HJ; van Eickels M; Gaudin C; Torp-Pedersen C; Hohnloser SH;
    Am J Cardiol; 2011 Apr; 107(7):1019-22. PubMed ID: 21296333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dronedarone: a new treatment for atrial fibrillation.
    Laughlin JC; Kowey PR
    J Cardiovasc Electrophysiol; 2008 Nov; 19(11):1220-6. PubMed ID: 18702618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of dronedarone: a review of randomized trials.
    Christiansen CB; Torp-Pedersen C; Køber L
    Expert Opin Drug Saf; 2010 Jan; 9(1):189-99. PubMed ID: 20001756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.
    Singh BN; Connolly SJ; Crijns HJ; Roy D; Kowey PR; Capucci A; Radzik D; Aliot EM; Hohnloser SH;
    N Engl J Med; 2007 Sep; 357(10):987-99. PubMed ID: 17804843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dronedarone: an overview.
    Kozlowski D; Budrejko S; Lip GY; Mikhailidis DP; Rysz J; Raczak G; Banach M
    Ann Med; 2012 Feb; 44(1):60-72. PubMed ID: 21745093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dronedarone: an emerging therapy for atrial fibrillation.
    Rosei EA; Salvetti M
    Ther Adv Cardiovasc Dis; 2010 Jun; 4(3):155-64. PubMed ID: 20418270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dronedarone: a new antiarrhythmic agent for the treatment of atrial fibrillation.
    Garcia D; Cheng-Lai A
    Cardiol Rev; 2009; 17(5):230-4. PubMed ID: 19690474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation.
    Piccini JP; Hasselblad V; Peterson ED; Washam JB; Califf RM; Kong DF
    J Am Coll Cardiol; 2009 Sep; 54(12):1089-95. PubMed ID: 19744618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.
    Connolly SJ; Crijns HJ; Torp-Pedersen C; van Eickels M; Gaudin C; Page RL; Hohnloser SH;
    Circulation; 2009 Sep; 120(13):1174-80. PubMed ID: 19752319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dronedarone or amiodarone for rhythm control for atrial fibrillation: implications from the DIONYSOS study.
    Pamukcu B; Lip GY
    Expert Opin Pharmacother; 2010 Dec; 11(17):2775-8. PubMed ID: 21050033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dronedarone: a novel antiarrhythmic agent for the treatment of atrial fibrillation.
    Duray GZ; Ehrlich JR; Hohnloser SH
    Curr Opin Cardiol; 2010 Jan; 25(1):53-8. PubMed ID: 19881340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dronedarone: current evidence and future questions.
    Schafer JA; Kjesbo NK; Gleason PP
    Cardiovasc Ther; 2010; 28(1):38-47. PubMed ID: 20074258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dronedarone: an amiodarone analog for the treatment of atrial fibrillation and atrial flutter.
    Dale KM; White CM
    Ann Pharmacother; 2007 Apr; 41(4):599-605. PubMed ID: 17389667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dronedarone.
    Patel C; Yan GX; Kowey PR
    Circulation; 2009 Aug; 120(7):636-44. PubMed ID: 19687370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dronedarone.
    Tamargo J; López-Farré A; Caballero R; Delpón E
    Drugs Today (Barc); 2011 Feb; 47(2):109-33. PubMed ID: 21431100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the appropriate and inappropriate use of dronedarone: lessons learned from controlled studies and regulatory submission.
    Naccarelli GV; Wolbrette DL; Samii S; Banchs JE; Penny-Peterson E; Gonzalez MD
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):24S-30S. PubMed ID: 21098416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale and design of ATHENA: A placebo-controlled, double-blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause in patiENts with Atrial fibrillation/atrial flutter.
    Hohnloser SH; Connolly SJ; Crijns HJ; Page RL; Seiz W; Torp-Petersen C
    J Cardiovasc Electrophysiol; 2008 Jan; 19(1):69-73. PubMed ID: 18031520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.